 | • レポートコード：GIR-107A12270 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、外部神経調節装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。外部神経調節装置の種類別市場規模（経皮的電気刺激、経頭蓋磁気刺激、呼吸電気刺激）、用途別市場規模（脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・外部神経調節装置の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Medtronic, Inc. (US)、Boston Scientific Corporation (US)、St. Jude Medical, Inc. (US)、Synapse Biomedical, Inc. (US)、Nevro Corporation (US)、Neurosigma, Inc. (US)、Neuropace, Inc. (US)、Neuronetics, Inc. (US)、Cyberonics, Inc. (US)、BioControl Medical (Israel) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：経皮的電気刺激、経頭蓋磁気刺激、呼吸電気刺激 ・用途別分析2016年-2026年：脊髄刺激、脳深部刺激療法、仙骨神経刺激療法、その他 ・外部神経調節装置の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・外部神経調節装置のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・外部神経調節装置のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・外部神経調節装置の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・外部神経調節装置の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The External Neuromodulation market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global External Neuromodulation size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global External Neuromodulation market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
External Neuromodulation market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transcutaneous Electrical Nerve Stimulation
Transcranial Magnetic Stimulation
Respiratory Electrical Stimulation
Market segment by Application, can be divided into
Spinal Cord Stimulation
Deep Brain Stimulation
Sacral Nerve Stimulation
Others
Market segment by players, this report covers
Medtronic, Inc. (US)
Boston Scientific Corporation (US)
St. Jude Medical, Inc. (US)
Synapse Biomedical, Inc. (US)
Nevro Corporation (US)
Neurosigma, Inc. (US)
Neuropace, Inc. (US)
Neuronetics, Inc. (US)
Cyberonics, Inc. (US)
BioControl Medical (Israel)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe External Neuromodulation product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of External Neuromodulation, with revenue, gross margin and global market share of External Neuromodulation from 2019 to 2021.
Chapter 3, the External Neuromodulation competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and External Neuromodulation market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe External Neuromodulation research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of External Neuromodulation
1.2 Classification of External Neuromodulation by Type
1.2.1 Overview: Global External Neuromodulation Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global External Neuromodulation Revenue Market Share by Type in 2020
1.2.3 Transcutaneous Electrical Nerve Stimulation
1.2.4 Transcranial Magnetic Stimulation
1.2.5 Respiratory Electrical Stimulation
1.3 Global External Neuromodulation Market by Application
1.3.1 Overview: Global External Neuromodulation Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Spinal Cord Stimulation
1.3.3 Deep Brain Stimulation
1.3.4 Sacral Nerve Stimulation
1.3.5 Others
1.4 Global External Neuromodulation Market Size & Forecast
1.5 Global External Neuromodulation Market Size and Forecast by Region
1.5.1 Global External Neuromodulation Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global External Neuromodulation Market Size by Region, (2016-2021)
1.5.3 North America External Neuromodulation Market Size and Prospect (2016-2026)
1.5.4 Europe External Neuromodulation Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific External Neuromodulation Market Size and Prospect (2016-2026)
1.5.6 South America External Neuromodulation Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa External Neuromodulation Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 External Neuromodulation Market Drivers
1.6.2 External Neuromodulation Market Restraints
1.6.3 External Neuromodulation Trends Analysis
2 Company Profiles
2.1 Medtronic, Inc. (US)
2.1.1 Medtronic, Inc. (US) Details
2.1.2 Medtronic, Inc. (US) Major Business
2.1.3 Medtronic, Inc. (US) External Neuromodulation Product and Solutions
2.1.4 Medtronic, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Medtronic, Inc. (US) Recent Developments and Future Plans
2.2 Boston Scientific Corporation (US)
2.2.1 Boston Scientific Corporation (US) Details
2.2.2 Boston Scientific Corporation (US) Major Business
2.2.3 Boston Scientific Corporation (US) External Neuromodulation Product and Solutions
2.2.4 Boston Scientific Corporation (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Boston Scientific Corporation (US) Recent Developments and Future Plans
2.3 St. Jude Medical, Inc. (US)
2.3.1 St. Jude Medical, Inc. (US) Details
2.3.2 St. Jude Medical, Inc. (US) Major Business
2.3.3 St. Jude Medical, Inc. (US) External Neuromodulation Product and Solutions
2.3.4 St. Jude Medical, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 St. Jude Medical, Inc. (US) Recent Developments and Future Plans
2.4 Synapse Biomedical, Inc. (US)
2.4.1 Synapse Biomedical, Inc. (US) Details
2.4.2 Synapse Biomedical, Inc. (US) Major Business
2.4.3 Synapse Biomedical, Inc. (US) External Neuromodulation Product and Solutions
2.4.4 Synapse Biomedical, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Synapse Biomedical, Inc. (US) Recent Developments and Future Plans
2.5 Nevro Corporation (US)
2.5.1 Nevro Corporation (US) Details
2.5.2 Nevro Corporation (US) Major Business
2.5.3 Nevro Corporation (US) External Neuromodulation Product and Solutions
2.5.4 Nevro Corporation (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Nevro Corporation (US) Recent Developments and Future Plans
2.6 Neurosigma, Inc. (US)
2.6.1 Neurosigma, Inc. (US) Details
2.6.2 Neurosigma, Inc. (US) Major Business
2.6.3 Neurosigma, Inc. (US) External Neuromodulation Product and Solutions
2.6.4 Neurosigma, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Neurosigma, Inc. (US) Recent Developments and Future Plans
2.7 Neuropace, Inc. (US)
2.7.1 Neuropace, Inc. (US) Details
2.7.2 Neuropace, Inc. (US) Major Business
2.7.3 Neuropace, Inc. (US) External Neuromodulation Product and Solutions
2.7.4 Neuropace, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Neuropace, Inc. (US) Recent Developments and Future Plans
2.8 Neuronetics, Inc. (US)
2.8.1 Neuronetics, Inc. (US) Details
2.8.2 Neuronetics, Inc. (US) Major Business
2.8.3 Neuronetics, Inc. (US) External Neuromodulation Product and Solutions
2.8.4 Neuronetics, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Neuronetics, Inc. (US) Recent Developments and Future Plans
2.9 Cyberonics, Inc. (US)
2.9.1 Cyberonics, Inc. (US) Details
2.9.2 Cyberonics, Inc. (US) Major Business
2.9.3 Cyberonics, Inc. (US) External Neuromodulation Product and Solutions
2.9.4 Cyberonics, Inc. (US) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Cyberonics, Inc. (US) Recent Developments and Future Plans
2.10 BioControl Medical (Israel)
2.10.1 BioControl Medical (Israel) Details
2.10.2 BioControl Medical (Israel) Major Business
2.10.3 BioControl Medical (Israel) External Neuromodulation Product and Solutions
2.10.4 BioControl Medical (Israel) External Neuromodulation Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 BioControl Medical (Israel) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global External Neuromodulation Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 External Neuromodulation Players Market Share
3.2.2 Top 10 External Neuromodulation Players Market Share
3.2.3 Market Competition Trend
3.3 External Neuromodulation Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global External Neuromodulation Revenue and Market Share by Type (2016-2021)
4.2 Global External Neuromodulation Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global External Neuromodulation Revenue Market Share by Application (2016-2021)
5.2 External Neuromodulation Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America External Neuromodulation Revenue by Type (2016-2026)
6.2 North America External Neuromodulation Revenue by Application (2016-2026)
6.3 North America External Neuromodulation Market Size by Country
6.3.1 North America External Neuromodulation Revenue by Country (2016-2026)
6.3.2 United States External Neuromodulation Market Size and Forecast (2016-2026)
6.3.3 Canada External Neuromodulation Market Size and Forecast (2016-2026)
6.3.4 Mexico External Neuromodulation Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe External Neuromodulation Revenue by Type (2016-2026)
7.2 Europe External Neuromodulation Revenue by Application (2016-2026)
7.3 Europe External Neuromodulation Market Size by Country
7.3.1 Europe External Neuromodulation Revenue by Country (2016-2026)
7.3.2 Germany External Neuromodulation Market Size and Forecast (2016-2026)
7.3.3 France External Neuromodulation Market Size and Forecast (2016-2026)
7.3.4 United Kingdom External Neuromodulation Market Size and Forecast (2016-2026)
7.3.5 Russia External Neuromodulation Market Size and Forecast (2016-2026)
7.3.6 Italy External Neuromodulation Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific External Neuromodulation Revenue by Type (2016-2026)
8.2 Asia-Pacific External Neuromodulation Revenue by Application (2016-2026)
8.3 Asia-Pacific External Neuromodulation Market Size by Region
8.3.1 Asia-Pacific External Neuromodulation Revenue by Region (2016-2026)
8.3.2 China External Neuromodulation Market Size and Forecast (2016-2026)
8.3.3 Japan External Neuromodulation Market Size and Forecast (2016-2026)
8.3.4 South Korea External Neuromodulation Market Size and Forecast (2016-2026)
8.3.5 India External Neuromodulation Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia External Neuromodulation Market Size and Forecast (2016-2026)
8.3.7 Australia External Neuromodulation Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America External Neuromodulation Revenue by Type (2016-2026)
9.2 South America External Neuromodulation Revenue by Application (2016-2026)
9.3 South America External Neuromodulation Market Size by Country
9.3.1 South America External Neuromodulation Revenue by Country (2016-2026)
9.3.2 Brazil External Neuromodulation Market Size and Forecast (2016-2026)
9.3.3 Argentina External Neuromodulation Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa External Neuromodulation Revenue by Type (2016-2026)
10.2 Middle East & Africa External Neuromodulation Revenue by Application (2016-2026)
10.3 Middle East & Africa External Neuromodulation Market Size by Country
10.3.1 Middle East & Africa External Neuromodulation Revenue by Country (2016-2026)
10.3.2 Turkey External Neuromodulation Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia External Neuromodulation Market Size and Forecast (2016-2026)
10.3.4 UAE External Neuromodulation Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global External Neuromodulation Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global External Neuromodulation Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market External Neuromodulation Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global External Neuromodulation Revenue (USD Million) by Region (2016-2021)
Table 5. Global External Neuromodulation Revenue Market Share by Region (2021-2026)
Table 6. Medtronic, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 7. Medtronic, Inc. (US) Major Business
Table 8. Medtronic, Inc. (US) External Neuromodulation Product and Solutions
Table 9. Medtronic, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Boston Scientific Corporation (US) Corporate Information, Head Office, and Major Competitors
Table 11. Boston Scientific Corporation (US) Major Business
Table 12. Boston Scientific Corporation (US) External Neuromodulation Product and Solutions
Table 13. Boston Scientific Corporation (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. St. Jude Medical, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 15. St. Jude Medical, Inc. (US) Major Business
Table 16. St. Jude Medical, Inc. (US) External Neuromodulation Product and Solutions
Table 17. St. Jude Medical, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Synapse Biomedical, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 19. Synapse Biomedical, Inc. (US) Major Business
Table 20. Synapse Biomedical, Inc. (US) External Neuromodulation Product and Solutions
Table 21. Synapse Biomedical, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Nevro Corporation (US) Corporate Information, Head Office, and Major Competitors
Table 23. Nevro Corporation (US) Major Business
Table 24. Nevro Corporation (US) External Neuromodulation Product and Solutions
Table 25. Nevro Corporation (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Neurosigma, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 27. Neurosigma, Inc. (US) Major Business
Table 28. Neurosigma, Inc. (US) External Neuromodulation Product and Solutions
Table 29. Neurosigma, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Neuropace, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 31. Neuropace, Inc. (US) Major Business
Table 32. Neuropace, Inc. (US) External Neuromodulation Product and Solutions
Table 33. Neuropace, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Neuronetics, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 35. Neuronetics, Inc. (US) Major Business
Table 36. Neuronetics, Inc. (US) External Neuromodulation Product and Solutions
Table 37. Neuronetics, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Cyberonics, Inc. (US) Corporate Information, Head Office, and Major Competitors
Table 39. Cyberonics, Inc. (US) Major Business
Table 40. Cyberonics, Inc. (US) External Neuromodulation Product and Solutions
Table 41. Cyberonics, Inc. (US) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. BioControl Medical (Israel) Corporate Information, Head Office, and Major Competitors
Table 43. BioControl Medical (Israel) Major Business
Table 44. BioControl Medical (Israel) External Neuromodulation Product and Solutions
Table 45. BioControl Medical (Israel) External Neuromodulation Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global External Neuromodulation Revenue (USD Million) by Players (2019-2021)
Table 47. Global External Neuromodulation Revenue Share by Players (2019-2021)
Table 48. Breakdown of External Neuromodulation by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. External Neuromodulation Players Head Office, Products and Services Provided
Table 50. External Neuromodulation Mergers & Acquisitions in the Past Five Years
Table 51. External Neuromodulation New Entrants and Expansion Plans
Table 52. Global External Neuromodulation Revenue (USD Million) by Type (2016-2021)
Table 53. Global External Neuromodulation Revenue Share by Type (2016-2021)
Table 54. Global External Neuromodulation Revenue Forecast by Type (2021-2026)
Table 55. Global External Neuromodulation Revenue by Application (2016-2021)
Table 56. Global External Neuromodulation Revenue Forecast by Application (2021-2026)
Table 57. North America External Neuromodulation Revenue by Type (2016-2021) & (USD Million)
Table 58. North America External Neuromodulation Revenue by Type (2021-2026) & (USD Million)
Table 59. North America External Neuromodulation Revenue by Application (2016-2021) & (USD Million)
Table 60. North America External Neuromodulation Revenue by Application (2021-2026) & (USD Million)
Table 61. North America External Neuromodulation Revenue by Country (2016-2021) & (USD Million)
Table 62. North America External Neuromodulation Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe External Neuromodulation Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe External Neuromodulation Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe External Neuromodulation Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe External Neuromodulation Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe External Neuromodulation Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe External Neuromodulation Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific External Neuromodulation Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific External Neuromodulation Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific External Neuromodulation Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific External Neuromodulation Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific External Neuromodulation Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific External Neuromodulation Revenue by Region (2021-2026) & (USD Million)
Table 75. South America External Neuromodulation Revenue by Type (2016-2021) & (USD Million)
Table 76. South America External Neuromodulation Revenue by Type (2021-2026) & (USD Million)
Table 77. South America External Neuromodulation Revenue by Application (2016-2021) & (USD Million)
Table 78. South America External Neuromodulation Revenue by Application (2021-2026) & (USD Million)
Table 79. South America External Neuromodulation Revenue by Country (2016-2021) & (USD Million)
Table 80. South America External Neuromodulation Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa External Neuromodulation Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa External Neuromodulation Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa External Neuromodulation Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa External Neuromodulation Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa External Neuromodulation Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa External Neuromodulation Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. External Neuromodulation Picture
Figure 2. Global External Neuromodulation Revenue Market Share by Type in 2020
Figure 3. Transcutaneous Electrical Nerve Stimulation
Figure 4. Transcranial Magnetic Stimulation
Figure 5. Respiratory Electrical Stimulation
Figure 6. External Neuromodulation Revenue Market Share by Application in 2020
Figure 7. Spinal Cord Stimulation Picture
Figure 8. Deep Brain Stimulation Picture
Figure 9. Sacral Nerve Stimulation Picture
Figure 10. Others Picture
Figure 11. Global External Neuromodulation Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global External Neuromodulation Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global External Neuromodulation Revenue Market Share by Region (2016-2026)
Figure 14. Global External Neuromodulation Revenue Market Share by Region in 2020
Figure 15. North America External Neuromodulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe External Neuromodulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific External Neuromodulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America External Neuromodulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa External Neuromodulation Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. External Neuromodulation Market Drivers
Figure 21. External Neuromodulation Market Restraints
Figure 22. External Neuromodulation Market Trends
Figure 23. Medtronic, Inc. (US) Recent Developments and Future Plans
Figure 24. Boston Scientific Corporation (US) Recent Developments and Future Plans
Figure 25. St. Jude Medical, Inc. (US) Recent Developments and Future Plans
Figure 26. Synapse Biomedical, Inc. (US) Recent Developments and Future Plans
Figure 27. Nevro Corporation (US) Recent Developments and Future Plans
Figure 28. Neurosigma, Inc. (US) Recent Developments and Future Plans
Figure 29. Neuropace, Inc. (US) Recent Developments and Future Plans
Figure 30. Neuronetics, Inc. (US) Recent Developments and Future Plans
Figure 31. Cyberonics, Inc. (US) Recent Developments and Future Plans
Figure 32. BioControl Medical (Israel) Recent Developments and Future Plans
Figure 33. Global External Neuromodulation Revenue Share by Players in 2020
Figure 34. External Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players External Neuromodulation Revenue Market Share in 2020
Figure 36. Global Top 10 Players External Neuromodulation Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global External Neuromodulation Revenue Share by Type in 2020
Figure 39. Global External Neuromodulation Market Share Forecast by Type (2021-2026)
Figure 40. Global External Neuromodulation Revenue Share by Application in 2020
Figure 41. Global External Neuromodulation Market Share Forecast by Application (2021-2026)
Figure 42. North America External Neuromodulation Sales Market Share by Type (2016-2026)
Figure 43. North America External Neuromodulation Sales Market Share by Application (2016-2026)
Figure 44. North America External Neuromodulation Revenue Market Share by Country (2016-2026)
Figure 45. United States External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe External Neuromodulation Sales Market Share by Type (2016-2026)
Figure 49. Europe External Neuromodulation Sales Market Share by Application (2016-2026)
Figure 50. Europe External Neuromodulation Revenue Market Share by Country (2016-2026)
Figure 51. Germany External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific External Neuromodulation Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific External Neuromodulation Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific External Neuromodulation Revenue Market Share by Region (2016-2026)
Figure 59. China External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America External Neuromodulation Sales Market Share by Type (2016-2026)
Figure 66. South America External Neuromodulation Sales Market Share by Application (2016-2026)
Figure 67. South America External Neuromodulation Revenue Market Share by Country (2016-2026)
Figure 68. Brazil External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa External Neuromodulation Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa External Neuromodulation Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa External Neuromodulation Revenue Market Share by Country (2016-2026)
Figure 73. Turkey External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE External Neuromodulation Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の経皮的電気神経刺激（TENS）デバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Transcutaneous electrical nerve stimulation (TENS) Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This re…- 世界の経皮的電気神経刺激（TENS）デバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Transcutaneous electrical nerve stimulation (TENS) Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This re…
- 世界の電気刺激療法市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Electrical Stimulation Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in C…
- 世界の仙骨神経刺激（SNS）デバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Sacral Nerve Stimulation (SNS) Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the …
- 世界の仙骨神経刺激（SNS）デバイス市場予測（～2024年）：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Sacral Nerve Stimulation (SNS) Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the …